
The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
| 1 Year | 5 Year | 5 Year Annualized | Since IPO | |
|---|---|---|---|---|
| VMD | +19.33% | -10.24% | -2.14% | +413% |
| S&P | +20.12% | +68.19% | +10.95% | +143% |
Viemed Healthcare, Inc. engages in the provision of home healthcare solutions. Through its subsidiaries, it supplies home medical equipment which provides post-acute respiratory services. It also offers respiratory disease management and in-home sleep testing and sleep apnea treatment. The company was founded by Casey Hoyt, Max Hoyt, and Michael Moore in 2016 and is headquartered in Lafayette, LA.
| Q4 2025 | YOY Change | |
|---|---|---|
| Revenue | $76.18M | 25.5% |
| Gross Profit | $43.72M | 22.1% |
| Gross Margin | 57.38% | -1.6% |
| Market Cap | $282.47M | -9.5% |
| Market Cap / Employee | $204.39K | 0.0% |
| Employees | 1.4K | 17.2% |
| Net Income | $5.82M | 31.5% |
| EBITDA | $16.37M | 39.6% |
Currently no data to display
Currently no data to display.
Currently no data to display.
| Q4 2025 | YOY Change | |
|---|---|---|
| Net Cash | $13.50M | -23.0% |
| Accounts Receivable | $25.59M | 2.7% |
| Inventory | 5 | 16.8% |
| Q4 2025 | YOY Change | |
|---|---|---|
| Long Term Debt | $13.66M | 144.0% |
| Short Term Debt | $2.29M | 80.6% |
| Q4 2025 | YOY Change | |
|---|---|---|
| Return On Assets | 7.62% | 0.8% |
| Return On Invested Capital | 13.58% | -1.5% |
| Q4 2025 | YOY Change | |
|---|---|---|
| Free Cash Flow | $9.70M | 207.3% |
| Operating Free Cash Flow | $18.44M | 23.0% |
| Metric | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | YoY Change |
|---|---|---|---|---|---|
| Price to Earnings | 24.40 | 20.39 | 20.54 | 19.81 | -32.14% |
| Price to Book | 2.17 | 2.03 | 1.92 | 2.11 | -15.39% |
| Price to Sales | 1.30 | 1.18 | 1.08 | 1.05 | -29.62% |
| Price to Tangible Book Value | 2.92 | 2.71 | 2.54 | 3.83 | 11.67% |
| Price to Free Cash Flow TTM | 85.11 | 252.66 | 51.06 | 23.68 | -27.12% |
| Enterprise Value to EBITDA | 36.92 | 23.91 | 20.02 | 17.53 | -36.62% |
| Free Cash Flow Yield | 1.2% | 0.4% | 2.0% | 4.2% | 37.22% |
| Return on Equity | 9.8% | 10.8% | 10.5% | 10.9% | 19.14% |
| Total Debt | $6.76M | $6.89M | $24.70M | $15.95M | 132.27% |
No podcast episodes available.
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.